GE HealthCare Technologies (NASDAQ:GEHC) Price Target Raised to $83.00

GE HealthCare Technologies (NASDAQ:GEHC) had its price objective boosted by BTIG Research from $75.00 to $83.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. BTIG Research‘s target price would suggest a potential upside of 7.92% from the company’s previous close.

Several other equities research analysts also recently commented on GEHC. Oppenheimer reiterated an “outperform” rating on shares of GE HealthCare Technologies in a report on Thursday, July 30th. Piper Sandler reissued a “buy” rating on shares of GE HealthCare Technologies in a report on Wednesday, July 29th. Citigroup lowered their price objective on shares of GE HealthCare Technologies from $75.00 to $71.00 and set a “neutral” rating on the stock in a research report on Monday, October 5th. UBS Group raised their target price on shares of GE HealthCare Technologies from $67.00 to $73.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. Finally, Zacks Research raised shares of GE HealthCare Technologies from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $78.70.

GE HealthCare Technologies Stock Up 8.2%

GEHC stock traded up $5.80 during midday trading on Wednesday, hitting $76.91. The company’s stock had a trading volume of 5,169,222 shares, compared to its average volume of 4,218,494. The company has a market cap of $34.74 billion, a PE ratio of 17.64, a P/E/G ratio of 1.89 and a beta of 0.73. GE HealthCare Technologies has a 12 month low of $58.75 and a 12 month high of $89.77. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.92. The firm’s 50-day moving average is $68.30 and its 200-day moving average is $70.23.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, October 28th. The company reported $1.34 EPS for the quarter, topping analysts’ consensus estimates of $1.20 by $0.14. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%. The business had revenue of $5.51 billion during the quarter, compared to analyst estimates of $5.35 billion. During the same quarter last year, the company earned $1.07 EPS. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. On average, equities research analysts forecast that GE HealthCare Technologies will post 4.93 earnings per share for the current fiscal year.

Institutional Investors Weigh In On GE HealthCare Technologies

Hedge funds and other institutional investors have recently modified their holdings of the stock. NBH Bank bought a new position in GE HealthCare Technologies in the 2nd quarter worth $26,000. Physician Wealth Advisors Inc. increased its position in GE HealthCare Technologies by 60.4% in the first quarter. Physician Wealth Advisors Inc. now owns 433 shares of the company’s stock worth $31,000 after buying an additional 163 shares in the last quarter. Global Assets Advisory LLC bought a new position in shares of GE HealthCare Technologies in the first quarter worth about $37,000. Fortitude Family Office LLC grew its stake in shares of GE HealthCare Technologies by 249.1% during the 3rd quarter. Fortitude Family Office LLC now owns 597 shares of the company’s stock valued at $39,000 after acquiring an additional 426 shares during the period. Finally, Aberdeen Wealth Management LLC bought a new position in shares of GE HealthCare Technologies during the 2nd quarter valued at approximately $44,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies News Roundup

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: GE HealthCare reported third-quarter adjusted earnings of $1.34 per share, above the $1.20-$1.21 analyst consensus and up from $1.07 a year earlier. Revenue rose 7.2% year over year to $5.51 billion, exceeding estimates of roughly $5.35 billion. GE HealthCare Technologies Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management cited strong top-line growth, margin expansion across all segments, disciplined operations and continued customer adoption of new products. Higher earnings and improved operating performance supported the increase in the company’s fiscal 2026 guidance. GE HealthCare Reports Third Quarter 2026 Financial Results
• Positive Sentiment: Analysts highlighted broad segment growth and higher margins as the main drivers of the earnings beat, suggesting that strong imaging demand and GE HealthCare’s backlog are translating into improved profitability. GEHC Q3 Earnings Beat Estimates on Strong Growth, 2026 View Raised
• Neutral Sentiment: Jeannette Bankes, president and CEO of Patient Care Solutions, will leave GE HealthCare for a CEO position at another company. The leadership change could create a near-term transition issue, although no operational impact was announced. GE HealthCare Shares Rise on Higher Q3 Results and FY26 Outlook Upgrade
• Negative Sentiment: Before the results, investors were watching for inflation, supply-chain constraints and potential weakness in Patient Care Solutions to pressure margins. The quarter’s margin expansion and guidance increase appear to have reduced those concerns, but they remain risks to monitor. GEHC Ahead of Q3 Earnings

About GE HealthCare Technologies

GE HealthCare Technologies Inc is a global medical technology company that develops and provides products, services and digital solutions for healthcare providers. Its offerings are designed to support the diagnosis, treatment and monitoring of patients across hospitals, outpatient facilities, imaging centers and other care settings.

The company’s portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, molecular imaging, surgical imaging and X-ray equipment.